Expression of Various Matrix Proteases and Ets Family Transcriptional Factors in Ovarian Cancer Cell Lines: Correlation to Invasive Potential
Objectives. The aim of our study was to determine the important molecules responsible for the invasive activity of ovarian cancer cells. Methods. We compared the biological characteristics, that is, growth rate, motility, and invasive activity, of five ovarian cancer cell lines with the gene express...
Gespeichert in:
Veröffentlicht in: | Gynecologic oncology 2000-11, Vol.79 (2), p.256-263 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 263 |
---|---|
container_issue | 2 |
container_start_page | 256 |
container_title | Gynecologic oncology |
container_volume | 79 |
creator | Nishikawa, Akira Iwasaki, Masahiro Akutagawa, Noriyuki Manase, Kengo Yamashita, Satoko Endo, Toshiaki Kudo, Ryuichi |
description | Objectives. The aim of our study was to determine the important molecules responsible for the invasive activity of ovarian cancer cells.
Methods. We compared the biological characteristics, that is, growth rate, motility, and invasive activity, of five ovarian cancer cell lines with the gene expression of various matrix proteases (matrix metalloproteinase-1 [MMP-1], MMP-2, MMP-9, membrane-type MMP type 1 [MT1-MMP], MT2-MMP, MT3-MMP, urokinase plasminogen activator [uPA]), their inhibitors (tissue inhibitor of metalloproteinase type 1 [TIMP-1], TIMP-2, plasminogen activator inhibitor type 1, [PAI-1], and PAI-2), and the potential transcriptional regulators E1AF and Ets-1.
Results. There was no clear correlation in the growth rate, motility, and invasion, suggesting that there are independent properties for malignant potential in ovarian cancer cells. However, HTBOA, a poorly differentiated cancer cell line, exhibited highly invasive activity, rapid growth, and increased motility. This cell line also expressed both Ets transcriptional factors, E1AF and Ets-1, and many matrix-degrading enzymes. Three cell lines that expressed E1AF showed rapid cell growth. The highly invasive cell lines, HTBOA and HTOA (well-differentiated serous cystadenocarcinoma), produced either MMP-2 or MMP-1, and both cell lines expressed MT1-MMP and uPA. Furthermore, the active forms of pro-MMP-2 and pro-MMP-1 were detected in HTBOA and HTOA by zymography.
Conclusion. We conclude that activated MMP-2 and MMP-1 are important in the invasive activity of these ovarian cancer cells. |
doi_str_mv | 10.1006/gyno.2000.5944 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72394001</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090825800959444</els_id><sourcerecordid>72394001</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-ce91af050b9aa56e2129c6d60edce4d74fbbe26228cd03bed032734c74f2edcf3</originalsourceid><addsrcrecordid>eNp1kcFv0zAUxi0EYmXjyhFZQtotxXYSN-GGog4mddoOY1frxXlBRqld_Nxq_SP4n3HUCk672JL9-z4_fx9jH6RYSiH0559HH5ZKCLGs26p6xRZStHWhm7p9zRZCtKJoVN1csHdEvzJVCqnesgsphS51XS3Yn_XzLiKRC56HkT9BdGFP_A5SdM_8IYaEQEgc_MDXifgNbN105I8RPNnodikLYcrHNoVI3Hl-f8ge4HkH3mLkHU4T3ziP9IV3IUacYNbwFPitPwC5A_KH_IpPDqYr9maEifD9eb9kP27Wj933YnP_7bb7uilspctUWGwljKIWfQtQa1RStVYPWuBgsRpW1dj3qLRSjR1E2WNe1KqsbL5QGRnLS3Z98t3F8HuPlMzWkc2Tgsf8fbNSZVsJITO4PIE2BqKIo9lFt4V4NFKYuQAzF2DmAsxcQBZ8PDvv-y0O__Fz4hn4dAaALExjDtI6-setWl2pMlPNicKcwsFhNGQd5kAHF9EmMwT30gR_AYBbpIw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72394001</pqid></control><display><type>article</type><title>Expression of Various Matrix Proteases and Ets Family Transcriptional Factors in Ovarian Cancer Cell Lines: Correlation to Invasive Potential</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Nishikawa, Akira ; Iwasaki, Masahiro ; Akutagawa, Noriyuki ; Manase, Kengo ; Yamashita, Satoko ; Endo, Toshiaki ; Kudo, Ryuichi</creator><creatorcontrib>Nishikawa, Akira ; Iwasaki, Masahiro ; Akutagawa, Noriyuki ; Manase, Kengo ; Yamashita, Satoko ; Endo, Toshiaki ; Kudo, Ryuichi</creatorcontrib><description>Objectives. The aim of our study was to determine the important molecules responsible for the invasive activity of ovarian cancer cells.
Methods. We compared the biological characteristics, that is, growth rate, motility, and invasive activity, of five ovarian cancer cell lines with the gene expression of various matrix proteases (matrix metalloproteinase-1 [MMP-1], MMP-2, MMP-9, membrane-type MMP type 1 [MT1-MMP], MT2-MMP, MT3-MMP, urokinase plasminogen activator [uPA]), their inhibitors (tissue inhibitor of metalloproteinase type 1 [TIMP-1], TIMP-2, plasminogen activator inhibitor type 1, [PAI-1], and PAI-2), and the potential transcriptional regulators E1AF and Ets-1.
Results. There was no clear correlation in the growth rate, motility, and invasion, suggesting that there are independent properties for malignant potential in ovarian cancer cells. However, HTBOA, a poorly differentiated cancer cell line, exhibited highly invasive activity, rapid growth, and increased motility. This cell line also expressed both Ets transcriptional factors, E1AF and Ets-1, and many matrix-degrading enzymes. Three cell lines that expressed E1AF showed rapid cell growth. The highly invasive cell lines, HTBOA and HTOA (well-differentiated serous cystadenocarcinoma), produced either MMP-2 or MMP-1, and both cell lines expressed MT1-MMP and uPA. Furthermore, the active forms of pro-MMP-2 and pro-MMP-1 were detected in HTBOA and HTOA by zymography.
Conclusion. We conclude that activated MMP-2 and MMP-1 are important in the invasive activity of these ovarian cancer cells.</description><identifier>ISSN: 0090-8258</identifier><identifier>EISSN: 1095-6859</identifier><identifier>DOI: 10.1006/gyno.2000.5944</identifier><identifier>PMID: 11063654</identifier><identifier>CODEN: GYNOA3</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Adenocarcinoma - genetics ; Adenocarcinoma - metabolism ; Adenocarcinoma - pathology ; Adenovirus E1A Proteins - biosynthesis ; Adenovirus E1A Proteins - genetics ; Biological and medical sciences ; Carcinoma, Endometrioid - enzymology ; Carcinoma, Endometrioid - genetics ; Carcinoma, Endometrioid - pathology ; Cell Division - physiology ; Cell Movement - physiology ; Cystadenocarcinoma, Serous - genetics ; Cystadenocarcinoma, Serous - metabolism ; Cystadenocarcinoma, Serous - pathology ; E1AF ; Enzyme Activation ; Enzyme Precursors - metabolism ; Ets ; Female ; Female genital diseases ; Gene Expression ; Gynecology. Andrology. Obstetrics ; Humans ; invasion ; Matrix Metalloproteinases - biosynthesis ; Matrix Metalloproteinases - genetics ; Matrix Metalloproteinases - metabolism ; matrix protease ; Medical sciences ; motility ; Neoplasm Invasiveness ; ovarian cancer ; Ovarian Neoplasms - enzymology ; Ovarian Neoplasms - metabolism ; Ovarian Neoplasms - pathology ; Plasminogen Activator Inhibitor 1 - biosynthesis ; Plasminogen Activator Inhibitor 1 - genetics ; Plasminogen Activator Inhibitor 2 - biosynthesis ; Plasminogen Activator Inhibitor 2 - genetics ; Proto-Oncogene Protein c-ets-1 ; Proto-Oncogene Proteins - biosynthesis ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins c-ets ; RNA, Messenger - biosynthesis ; RNA, Messenger - genetics ; Tissue Inhibitor of Metalloproteinase-1 - biosynthesis ; Tissue Inhibitor of Metalloproteinase-1 - genetics ; Tissue Inhibitor of Metalloproteinase-2 - biosynthesis ; Tissue Inhibitor of Metalloproteinase-2 - genetics ; Transcription Factors - biosynthesis ; Transcription Factors - genetics ; Tumor Cells, Cultured ; Tumors ; Urokinase-Type Plasminogen Activator - biosynthesis ; Urokinase-Type Plasminogen Activator - genetics ; Urokinase-Type Plasminogen Activator - metabolism</subject><ispartof>Gynecologic oncology, 2000-11, Vol.79 (2), p.256-263</ispartof><rights>2000 Academic Press</rights><rights>2001 INIST-CNRS</rights><rights>Copyright 2000 Academic Press.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-ce91af050b9aa56e2129c6d60edce4d74fbbe26228cd03bed032734c74f2edcf3</citedby><cites>FETCH-LOGICAL-c463t-ce91af050b9aa56e2129c6d60edce4d74fbbe26228cd03bed032734c74f2edcf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/gyno.2000.5944$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=796423$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11063654$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nishikawa, Akira</creatorcontrib><creatorcontrib>Iwasaki, Masahiro</creatorcontrib><creatorcontrib>Akutagawa, Noriyuki</creatorcontrib><creatorcontrib>Manase, Kengo</creatorcontrib><creatorcontrib>Yamashita, Satoko</creatorcontrib><creatorcontrib>Endo, Toshiaki</creatorcontrib><creatorcontrib>Kudo, Ryuichi</creatorcontrib><title>Expression of Various Matrix Proteases and Ets Family Transcriptional Factors in Ovarian Cancer Cell Lines: Correlation to Invasive Potential</title><title>Gynecologic oncology</title><addtitle>Gynecol Oncol</addtitle><description>Objectives. The aim of our study was to determine the important molecules responsible for the invasive activity of ovarian cancer cells.
Methods. We compared the biological characteristics, that is, growth rate, motility, and invasive activity, of five ovarian cancer cell lines with the gene expression of various matrix proteases (matrix metalloproteinase-1 [MMP-1], MMP-2, MMP-9, membrane-type MMP type 1 [MT1-MMP], MT2-MMP, MT3-MMP, urokinase plasminogen activator [uPA]), their inhibitors (tissue inhibitor of metalloproteinase type 1 [TIMP-1], TIMP-2, plasminogen activator inhibitor type 1, [PAI-1], and PAI-2), and the potential transcriptional regulators E1AF and Ets-1.
Results. There was no clear correlation in the growth rate, motility, and invasion, suggesting that there are independent properties for malignant potential in ovarian cancer cells. However, HTBOA, a poorly differentiated cancer cell line, exhibited highly invasive activity, rapid growth, and increased motility. This cell line also expressed both Ets transcriptional factors, E1AF and Ets-1, and many matrix-degrading enzymes. Three cell lines that expressed E1AF showed rapid cell growth. The highly invasive cell lines, HTBOA and HTOA (well-differentiated serous cystadenocarcinoma), produced either MMP-2 or MMP-1, and both cell lines expressed MT1-MMP and uPA. Furthermore, the active forms of pro-MMP-2 and pro-MMP-1 were detected in HTBOA and HTOA by zymography.
Conclusion. We conclude that activated MMP-2 and MMP-1 are important in the invasive activity of these ovarian cancer cells.</description><subject>Adenocarcinoma - genetics</subject><subject>Adenocarcinoma - metabolism</subject><subject>Adenocarcinoma - pathology</subject><subject>Adenovirus E1A Proteins - biosynthesis</subject><subject>Adenovirus E1A Proteins - genetics</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Endometrioid - enzymology</subject><subject>Carcinoma, Endometrioid - genetics</subject><subject>Carcinoma, Endometrioid - pathology</subject><subject>Cell Division - physiology</subject><subject>Cell Movement - physiology</subject><subject>Cystadenocarcinoma, Serous - genetics</subject><subject>Cystadenocarcinoma, Serous - metabolism</subject><subject>Cystadenocarcinoma, Serous - pathology</subject><subject>E1AF</subject><subject>Enzyme Activation</subject><subject>Enzyme Precursors - metabolism</subject><subject>Ets</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>Gene Expression</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>invasion</subject><subject>Matrix Metalloproteinases - biosynthesis</subject><subject>Matrix Metalloproteinases - genetics</subject><subject>Matrix Metalloproteinases - metabolism</subject><subject>matrix protease</subject><subject>Medical sciences</subject><subject>motility</subject><subject>Neoplasm Invasiveness</subject><subject>ovarian cancer</subject><subject>Ovarian Neoplasms - enzymology</subject><subject>Ovarian Neoplasms - metabolism</subject><subject>Ovarian Neoplasms - pathology</subject><subject>Plasminogen Activator Inhibitor 1 - biosynthesis</subject><subject>Plasminogen Activator Inhibitor 1 - genetics</subject><subject>Plasminogen Activator Inhibitor 2 - biosynthesis</subject><subject>Plasminogen Activator Inhibitor 2 - genetics</subject><subject>Proto-Oncogene Protein c-ets-1</subject><subject>Proto-Oncogene Proteins - biosynthesis</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins c-ets</subject><subject>RNA, Messenger - biosynthesis</subject><subject>RNA, Messenger - genetics</subject><subject>Tissue Inhibitor of Metalloproteinase-1 - biosynthesis</subject><subject>Tissue Inhibitor of Metalloproteinase-1 - genetics</subject><subject>Tissue Inhibitor of Metalloproteinase-2 - biosynthesis</subject><subject>Tissue Inhibitor of Metalloproteinase-2 - genetics</subject><subject>Transcription Factors - biosynthesis</subject><subject>Transcription Factors - genetics</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors</subject><subject>Urokinase-Type Plasminogen Activator - biosynthesis</subject><subject>Urokinase-Type Plasminogen Activator - genetics</subject><subject>Urokinase-Type Plasminogen Activator - metabolism</subject><issn>0090-8258</issn><issn>1095-6859</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kcFv0zAUxi0EYmXjyhFZQtotxXYSN-GGog4mddoOY1frxXlBRqld_Nxq_SP4n3HUCk672JL9-z4_fx9jH6RYSiH0559HH5ZKCLGs26p6xRZStHWhm7p9zRZCtKJoVN1csHdEvzJVCqnesgsphS51XS3Yn_XzLiKRC56HkT9BdGFP_A5SdM_8IYaEQEgc_MDXifgNbN105I8RPNnodikLYcrHNoVI3Hl-f8ge4HkH3mLkHU4T3ziP9IV3IUacYNbwFPitPwC5A_KH_IpPDqYr9maEifD9eb9kP27Wj933YnP_7bb7uilspctUWGwljKIWfQtQa1RStVYPWuBgsRpW1dj3qLRSjR1E2WNe1KqsbL5QGRnLS3Z98t3F8HuPlMzWkc2Tgsf8fbNSZVsJITO4PIE2BqKIo9lFt4V4NFKYuQAzF2DmAsxcQBZ8PDvv-y0O__Fz4hn4dAaALExjDtI6-setWl2pMlPNicKcwsFhNGQd5kAHF9EmMwT30gR_AYBbpIw</recordid><startdate>20001101</startdate><enddate>20001101</enddate><creator>Nishikawa, Akira</creator><creator>Iwasaki, Masahiro</creator><creator>Akutagawa, Noriyuki</creator><creator>Manase, Kengo</creator><creator>Yamashita, Satoko</creator><creator>Endo, Toshiaki</creator><creator>Kudo, Ryuichi</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20001101</creationdate><title>Expression of Various Matrix Proteases and Ets Family Transcriptional Factors in Ovarian Cancer Cell Lines: Correlation to Invasive Potential</title><author>Nishikawa, Akira ; Iwasaki, Masahiro ; Akutagawa, Noriyuki ; Manase, Kengo ; Yamashita, Satoko ; Endo, Toshiaki ; Kudo, Ryuichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-ce91af050b9aa56e2129c6d60edce4d74fbbe26228cd03bed032734c74f2edcf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adenocarcinoma - genetics</topic><topic>Adenocarcinoma - metabolism</topic><topic>Adenocarcinoma - pathology</topic><topic>Adenovirus E1A Proteins - biosynthesis</topic><topic>Adenovirus E1A Proteins - genetics</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Endometrioid - enzymology</topic><topic>Carcinoma, Endometrioid - genetics</topic><topic>Carcinoma, Endometrioid - pathology</topic><topic>Cell Division - physiology</topic><topic>Cell Movement - physiology</topic><topic>Cystadenocarcinoma, Serous - genetics</topic><topic>Cystadenocarcinoma, Serous - metabolism</topic><topic>Cystadenocarcinoma, Serous - pathology</topic><topic>E1AF</topic><topic>Enzyme Activation</topic><topic>Enzyme Precursors - metabolism</topic><topic>Ets</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>Gene Expression</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>invasion</topic><topic>Matrix Metalloproteinases - biosynthesis</topic><topic>Matrix Metalloproteinases - genetics</topic><topic>Matrix Metalloproteinases - metabolism</topic><topic>matrix protease</topic><topic>Medical sciences</topic><topic>motility</topic><topic>Neoplasm Invasiveness</topic><topic>ovarian cancer</topic><topic>Ovarian Neoplasms - enzymology</topic><topic>Ovarian Neoplasms - metabolism</topic><topic>Ovarian Neoplasms - pathology</topic><topic>Plasminogen Activator Inhibitor 1 - biosynthesis</topic><topic>Plasminogen Activator Inhibitor 1 - genetics</topic><topic>Plasminogen Activator Inhibitor 2 - biosynthesis</topic><topic>Plasminogen Activator Inhibitor 2 - genetics</topic><topic>Proto-Oncogene Protein c-ets-1</topic><topic>Proto-Oncogene Proteins - biosynthesis</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins c-ets</topic><topic>RNA, Messenger - biosynthesis</topic><topic>RNA, Messenger - genetics</topic><topic>Tissue Inhibitor of Metalloproteinase-1 - biosynthesis</topic><topic>Tissue Inhibitor of Metalloproteinase-1 - genetics</topic><topic>Tissue Inhibitor of Metalloproteinase-2 - biosynthesis</topic><topic>Tissue Inhibitor of Metalloproteinase-2 - genetics</topic><topic>Transcription Factors - biosynthesis</topic><topic>Transcription Factors - genetics</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors</topic><topic>Urokinase-Type Plasminogen Activator - biosynthesis</topic><topic>Urokinase-Type Plasminogen Activator - genetics</topic><topic>Urokinase-Type Plasminogen Activator - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nishikawa, Akira</creatorcontrib><creatorcontrib>Iwasaki, Masahiro</creatorcontrib><creatorcontrib>Akutagawa, Noriyuki</creatorcontrib><creatorcontrib>Manase, Kengo</creatorcontrib><creatorcontrib>Yamashita, Satoko</creatorcontrib><creatorcontrib>Endo, Toshiaki</creatorcontrib><creatorcontrib>Kudo, Ryuichi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gynecologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nishikawa, Akira</au><au>Iwasaki, Masahiro</au><au>Akutagawa, Noriyuki</au><au>Manase, Kengo</au><au>Yamashita, Satoko</au><au>Endo, Toshiaki</au><au>Kudo, Ryuichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of Various Matrix Proteases and Ets Family Transcriptional Factors in Ovarian Cancer Cell Lines: Correlation to Invasive Potential</atitle><jtitle>Gynecologic oncology</jtitle><addtitle>Gynecol Oncol</addtitle><date>2000-11-01</date><risdate>2000</risdate><volume>79</volume><issue>2</issue><spage>256</spage><epage>263</epage><pages>256-263</pages><issn>0090-8258</issn><eissn>1095-6859</eissn><coden>GYNOA3</coden><abstract>Objectives. The aim of our study was to determine the important molecules responsible for the invasive activity of ovarian cancer cells.
Methods. We compared the biological characteristics, that is, growth rate, motility, and invasive activity, of five ovarian cancer cell lines with the gene expression of various matrix proteases (matrix metalloproteinase-1 [MMP-1], MMP-2, MMP-9, membrane-type MMP type 1 [MT1-MMP], MT2-MMP, MT3-MMP, urokinase plasminogen activator [uPA]), their inhibitors (tissue inhibitor of metalloproteinase type 1 [TIMP-1], TIMP-2, plasminogen activator inhibitor type 1, [PAI-1], and PAI-2), and the potential transcriptional regulators E1AF and Ets-1.
Results. There was no clear correlation in the growth rate, motility, and invasion, suggesting that there are independent properties for malignant potential in ovarian cancer cells. However, HTBOA, a poorly differentiated cancer cell line, exhibited highly invasive activity, rapid growth, and increased motility. This cell line also expressed both Ets transcriptional factors, E1AF and Ets-1, and many matrix-degrading enzymes. Three cell lines that expressed E1AF showed rapid cell growth. The highly invasive cell lines, HTBOA and HTOA (well-differentiated serous cystadenocarcinoma), produced either MMP-2 or MMP-1, and both cell lines expressed MT1-MMP and uPA. Furthermore, the active forms of pro-MMP-2 and pro-MMP-1 were detected in HTBOA and HTOA by zymography.
Conclusion. We conclude that activated MMP-2 and MMP-1 are important in the invasive activity of these ovarian cancer cells.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>11063654</pmid><doi>10.1006/gyno.2000.5944</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0090-8258 |
ispartof | Gynecologic oncology, 2000-11, Vol.79 (2), p.256-263 |
issn | 0090-8258 1095-6859 |
language | eng |
recordid | cdi_proquest_miscellaneous_72394001 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Adenocarcinoma - genetics Adenocarcinoma - metabolism Adenocarcinoma - pathology Adenovirus E1A Proteins - biosynthesis Adenovirus E1A Proteins - genetics Biological and medical sciences Carcinoma, Endometrioid - enzymology Carcinoma, Endometrioid - genetics Carcinoma, Endometrioid - pathology Cell Division - physiology Cell Movement - physiology Cystadenocarcinoma, Serous - genetics Cystadenocarcinoma, Serous - metabolism Cystadenocarcinoma, Serous - pathology E1AF Enzyme Activation Enzyme Precursors - metabolism Ets Female Female genital diseases Gene Expression Gynecology. Andrology. Obstetrics Humans invasion Matrix Metalloproteinases - biosynthesis Matrix Metalloproteinases - genetics Matrix Metalloproteinases - metabolism matrix protease Medical sciences motility Neoplasm Invasiveness ovarian cancer Ovarian Neoplasms - enzymology Ovarian Neoplasms - metabolism Ovarian Neoplasms - pathology Plasminogen Activator Inhibitor 1 - biosynthesis Plasminogen Activator Inhibitor 1 - genetics Plasminogen Activator Inhibitor 2 - biosynthesis Plasminogen Activator Inhibitor 2 - genetics Proto-Oncogene Protein c-ets-1 Proto-Oncogene Proteins - biosynthesis Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins c-ets RNA, Messenger - biosynthesis RNA, Messenger - genetics Tissue Inhibitor of Metalloproteinase-1 - biosynthesis Tissue Inhibitor of Metalloproteinase-1 - genetics Tissue Inhibitor of Metalloproteinase-2 - biosynthesis Tissue Inhibitor of Metalloproteinase-2 - genetics Transcription Factors - biosynthesis Transcription Factors - genetics Tumor Cells, Cultured Tumors Urokinase-Type Plasminogen Activator - biosynthesis Urokinase-Type Plasminogen Activator - genetics Urokinase-Type Plasminogen Activator - metabolism |
title | Expression of Various Matrix Proteases and Ets Family Transcriptional Factors in Ovarian Cancer Cell Lines: Correlation to Invasive Potential |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T05%3A22%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20Various%20Matrix%20Proteases%20and%20Ets%20Family%20Transcriptional%20Factors%20in%20Ovarian%20Cancer%20Cell%20Lines:%20Correlation%20to%20Invasive%20Potential&rft.jtitle=Gynecologic%20oncology&rft.au=Nishikawa,%20Akira&rft.date=2000-11-01&rft.volume=79&rft.issue=2&rft.spage=256&rft.epage=263&rft.pages=256-263&rft.issn=0090-8258&rft.eissn=1095-6859&rft.coden=GYNOA3&rft_id=info:doi/10.1006/gyno.2000.5944&rft_dat=%3Cproquest_cross%3E72394001%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72394001&rft_id=info:pmid/11063654&rft_els_id=S0090825800959444&rfr_iscdi=true |